Review
Sep 2026
Precision therapeutic strategies for advanced gastrointestinal stromal tumors
A. Ooki, H. Osumi, K. Shimozaki et al.
· Cancer Metastasis Review · 0 citations
We have 3 of 75 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Open access
Aug 2026
Proteinuria as the cause of early dose modification in Japanese patients with metastatic colorectal cancer treated with fruquintinib: a multicenter real-world study.
Fruquintinib demonstrated feasible effectiveness and manageable toxicity in Japanese patients with mCRC and proteinuria was a major determinant of treatment feasibility and frequently led to early dose modification.
Shohei Udagawa, Chihiro Ishizuka, H. Osumi et al.
· International Journal of Cli... · 0 citations
Open access
Aug 2026
Prognostic impact of circulating tumor RAS and BRAF mutation dynamics in patients with metastatic colorectal cancer
Results show that post-treatment circulating tumor RAS and BRAF MT dynamics may serve as useful prognostic indicators, particularly with regard to BRAF MT.
H. Osumi, E. Shinozaki, Yoshiaki Nakamura et al.
· iScience · 0 citations